{"name":"RegeneRx Biopharmaceuticals, Inc.","slug":"regenerx-biopharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":76761,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":-1727455,"cash":382177,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2022"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE9vOGNlV0F3b2gyY01xV1E3ZDVmUnF6dWJIbERNeWdXSzJPRE9EcU9oemQxRGszdlRoaUZWZTJBYW9va3I4WWlFM0RrbjVIQ3dvak9yOGpwdW84QWd4YU0wMWJ3?oc=5","date":"2026-03-29","type":"pipeline","source":"GuruFocus","summary":"Stock List: Research Stocks from Around the World - GuruFocus","headline":"Stock List: Research Stocks from Around the World","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgJBVV95cUxPNENwZFNOUy00TGpWSmJHbWV1V2UwQU5QWjAyd2owSUdlcWV2aThqZDktLXdJLVJubmVIMFQtal8zRlgxTEY2T1U0eWFYU2d3enMwMXdYaHN4NjZKSGxOTTRTdzRXX2tFVzZOSlFLYW5ZOTE2Y1FIcXB5dFhFd2ZfdS1jdDRXVUpvTG1mUjZrYk9tcFIzbGl3YWVWZV90T3EwZ1pSeEVRdWhVT0dOb1JMZnMzMGJ1VVhWeUVxdG1hRGVia04zNnZGVTRKQUUxU3FRN0dFRGtHejlKRnJmMEx4R2x5Xzc1QVAyNS16R1A3WkFxR1VvZHdyUTREWnJYa2h2cUJlUVVmN29XMFVxZWk0MEtUdTlSWGs3Y0VNdnNCMXNCOUlieDZyTHgtX2FpYnJBN1E?oc=5","date":"2025-07-14","type":"pipeline","source":"PR Newswire","summary":"MCR Therapies Market Set to Grow Rapidly Across the 7MM During the Forecast Period (2020-2034) with New Indications and Pipeline Advancements | DelveInsight - PR Newswire","headline":"MCR Therapies Market Set to Grow Rapidly Across the 7MM During the Forecast Period (2020-2034) with New Indications and ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxNUTlueFcxMloxdHhmMklNRmVicU9oc1hZMkY1dElEeUNUeWJTdmV2YzJycktUNG1STmthZ1FOLXBweTM4WTZCZVF4TXc3VHVXS01rdUhfMXVUZmp4N3VBQUR5RkI2M2Q3b1pGaGNzeG5OZDF1YmdHWFZVQkkyMS1HTV9zMG96WEluMk12MU5XaEVWWHhhZXpmZ19Fd2pSelNuN0FoVXozMERsVHd0YnJVdlYyb1d1LTNJU1NQdWItM3hxZ3RlZ01mcw?oc=5","date":"2025-01-28","type":"pipeline","source":"PR Newswire","summary":"Dry Eye Disease Market to Observe Stupendous Growth by 2034 | DelveInsight - PR Newswire","headline":"Dry Eye Disease Market to Observe Stupendous Growth by 2034 | DelveInsight","sentiment":"neutral"},{"date":"2023-08-07","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"date":"2023-07-10","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"date":"2023-06-21","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"date":"2023-05-15","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQWXdvWnpON3NmWnBNbFlUajFqakJXa0w0OVNpU3pZcTZ6clpkWjNvLW04ZWdiTWtIVnFzUnFKSUdqanVHNjJ0QzZMalRPUTlacUp1YUxVX09fOFFyNFU1QmZ2dkw3czZnTjUwVWNWZmtYVlpOWGR0ZUNfLTZPNk91U2hFaFZLb2RZdWU2NVV0YWtOTlltdFBVR2JZMWc4dnF1ZFhpREJMaGFBOWVhek9hOQ?oc=5","date":"2023-04-21","type":"trial","source":"Eyes On Eyecare","summary":"Phase 3 neurotrophic keratitis trial enrolls first patient - Eyes On Eyecare","headline":"Phase 3 neurotrophic keratitis trial enrolls first patient","sentiment":"neutral"},{"date":"2023-04-11","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTFBjR1lIYUplYTJpWWI0R2w3ODBCN1QxcjV5VXBkZlJTcjBSR1R1LVExUGRIdEM2cXFVZTAxM3o0SnI2dW83TWEyT0FtT2VEZ1BZSmFoenFUdEdfVEVvRVdYWVFWb0VzNVdweVZlRWxzX291bkpn?oc=5","date":"2022-11-29","type":"pipeline","source":"GuruFocus","summary":"Farmaceutica Lda Defiante Net Worth (2026) - GuruFocus","headline":"Farmaceutica Lda Defiante Net Worth (2026)","sentiment":"neutral"},{"date":"2022-11-14","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2022-08-12","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2022-05-16","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gJBVV95cUxQYzFiVTIzMVluckFYZDUybkpoM1lseGdTdUFNdFBJY21ZM3lvbHZTbDk5WWJXSWZTNzZ3WHdHaUhaejZwYTZDdGxncGg2NVVwRlNrQUdBYjdsTTdkRGN1bXZIZ2tKNXQtanN1VmNtS1AyNmJvWDhBUFpFRHdiRVVmTXl4REFiOEowLWNYSWpPdE5LeVhHT3FqMEJUMVNoUkRGeXdCeWkyeWdlR1djN2hSaUJ6eUxTMFNyTlVRbW9ka2hneGZsVExrcE1WVjEzYXk4MTgwRkctWGtzMUZWdkdoUk9rWEZiOXFPVVZvX1hNWTFUVG9aMEZzcHJSNjFrcWxoc05VeXpHNVBqTkl3X3ZzZGxrdlhrUTFlRWxBU3NkdXktSUJDaHRVajc4ZzBRUndyRFQ0Yy1mRG1QX1RfTVNzYkQ1dU02TTM3aG9CN3NDN3FOYVpGWnc?oc=5","date":"2022-03-24","type":"pipeline","source":"GlobeNewswire","summary":"Peptide Therapeutics: Contract API Manufacturing Market - GlobeNewswire","headline":"Peptide Therapeutics: Contract API Manufacturing Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiSEFVX3lxTE12a2ZPbkd4VVpEVE56eTFyaTBuR3dvVkJ3YkZqYmRrcU9VWXBRQTJyZVh3Mk51SU4zRDBpYlVyR1BBdTF2Wl8xQw?oc=5","date":"2020-12-08","type":"deal","source":"StockInvest.us","summary":"Regenerx Biopharmaceuticals Stock Price Forecast. Should You Buy RGRX? - StockInvest.us","headline":"Regenerx Biopharmaceuticals Stock Price Forecast. Should You Buy RGRX?","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":76761,"revenuePeriod":"2022-12-31","revenueHistory":[{"value":76761,"period":"2022-12-31"},{"value":76761,"period":"2021-12-31"},{"value":76761,"period":"2021-12-31"},{"value":76761,"period":"2020-12-31"},{"value":76761,"period":"2020-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":0,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-1727455,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":382177,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}